During recent decades, the emergence of pathogenic fungi has posed an increasing public
health threat, particularly given the limited number of antifungal drugs available to treat …

Candida auris and Candida albicans can result in invasive fungal diseases. And yet, these
species can stably and asymptomatically colonize human skin and gastrointestinal tracts. To …

Candida auris is an emerging, multidrug resistant fungal pathogen that causes considerable
morbidity and mortality. First identified in Japan in 2009, it has since been reported in more …

Candida auris is an emerging multidrug-resistant fungal pathogen that can cause life-
threatening infections in humans. Unlike other Candida species that colonize the gut, C …

Candida auris was first described as a yeast pathogen in 2009. Since then, the species has
emerged worldwide. In contrast to most other Candida spp., C. auris frequently exhibits multi …

Fungal infections can cause severe disease and death and impose a substantial economic
burden on healthcare systems. Public health research requires a multidisciplinary approach …

Candida auris is a newly emerged multidrug-resistant fungus capable of causing invasive
infections with high mortality. Despite intense efforts to understand how this pathogen …

The pathogenic yeast Candida auris represents a global threat of the utmost clinical
relevance. This emerging fungal species is remarkable in its resistance to commonly used …

Background Environmental contamination is suspected to play an important role in Candida
auris transmission. Understanding speed and risks of contamination after room disinfection …

The recently emergent fungal pathogen Candida auris frequently persists on skin of patients
and can cause invasive disease with mortality rates over 50%[1, 2]. It is the first fungal …